Why This Tiny Biotech is Giving Cash to Amgen Researchers Post author:Sam Post published:August 30, 2017 Post category:BioPharma August 31, 2017By Mark Terry, BioSpace.com Breaking News StaffA tiny San… Source: BioSpace You Might Also Like 3 Biopharmas Worth Watching in 2018 January 14, 2018 In the Nick of Time: Galapagos Nabs Co-Promotion Filgotinib Deal With Gilead December 14, 2017 The Medicines Company To Present Data At On Infectious Disease Portfolio Including Recently Approved Antibiotic VABOMERE(Meropenem And Vaborbactam) September 28, 2017
The Medicines Company To Present Data At On Infectious Disease Portfolio Including Recently Approved Antibiotic VABOMERE(Meropenem And Vaborbactam) September 28, 2017
